Welcome to Ligand

Ligand Is Collaboration

At Ligand, we believe collaboration is an important part of successful drug discovery and development. We have forged numerous valuable research and development alliances with global pharmaceutical companies that have ongoing clinical programs.

Pharmaceutical partnerships include the following companies and span programs in large market indications, such as muscle wasting, frailty, hormone-related diseases, osteoporosis, inflammatory diseases, anemia, asthma, rheumatoid arthritis and psoriasis.

• GlaxoSmithKline
• Pfizer Inc.
• Bristol-Myers Squibb
• Merck
• Celgene
• Cephalon
• King Pharmaceuticals

Ligand Is Science

Our research and development programs—both within Ligand and with external partners—are built around our proprietary intracellular (IR) technology. Intracellar technology is the result of our ground-breaking work in the field of gene transcription. It is a powerful technology that has already generated numerous compounds which have advanced to late-stage clinical development.

Ligand Is Success

Ligand has the potential to realize profit streams from milestone and royalty revenues resulting from collaborations with pharmaceutical partners. Recently, we divested commercial assets, allowing us to focus on a business strategy that targets internal research and drug discovery that may provide future licensing opportunities.